New aspects in thyroid cancer treatment. Highlights of the ASCO Annual Meeting 2018

被引：0
|
作者：
Moeckelmann, N. [1 ]
Muenscher, A. [1 ]
机构：
[1] Univ Klinikum Hamburg Eppendorf, UCCH, Klin & Poliklin Hals Nasen & Ohrenheilkunde, Kopf Hals Tumorzentrum,Kopf Hals Chirurg, Martinistr 52, D-20246 Hamburg, Germany
来源：
HNO | 2018年 / 66卷 / 12期
关键词：
Thyroid cancer; Radioiodine-refractory; Anaplastic; Tyrosine kinase inhibitor; Immunotherapy;
D O I：
10.1007/s00106-018-0589-z
中图分类号：
R76 [耳鼻咽喉科学];
学科分类号：
100213 ;
摘要：
Whereas surgical treatment of thyroid carcinoma plays an important role especially in the early stages, a multimodal approach is pursued in the palliative setting, which, in addition to classical chemotherapy primarily involves treatment with tyrosine kinase inhibitors. An analysis of clinical trials and studies presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2018 is presented. In particular, studies on the treatment of radioiodine-refractory differentiated thyroid cancer, anaplastic thyroid cancer and immunotherapy were selected and analyzed. Clinically and preclinically relevant studies are presented and critically interpreted in this review.
引用
收藏
页码：896 / 900
页数：5
相关论文
共 50 条
  • [1] New aspects in thyroid cancer treatment. Highlights of the ASCO Annual Meeting 2015
    Loerincz, B. B.
    Topp, S.
    Knecht, R.
    [J]. HNO, 2015, 63 (09) : 625 - 628
  • [2] New aspects in thyroid cancer treatment Highlights of the 2019 ASCO Annual Meeting
    Moeckelmann, N.
    Betz, C.
    [J]. HNO, 2019, 67 (12) : 925 - 930
  • [3] New aspects in the treatment of thyroid cancer. Highlights of the ASCO Annual Meeting 2016
    Loerincz, B. B.
    Simon, C.
    Moeckelmann, N.
    Knecht, R.
    [J]. HNO, 2016, 64 (10) : 736 - 740
  • [4] Radiotherapeutic studies of head and neck cancer-highlights of the 2018 ASCO Annual Meeting
    Ott, S.
    Wiegel, T.
    Laban, S.
    Hoffmann, T. K.
    Petersen, C.
    Tribius, S.
    [J]. HNO, 2018, 66 (12) : 901 - 906
  • [5] Neue Aspekte in der Therapie von SchilddrüsenkarzinomenHighlights vom ASCO-Kongress 2018New aspects in thyroid cancer treatmentHighlights of the ASCO Annual Meeting 2018
    N. Möckelmann
    A. Münscher
    [J]. HNO, 2018, 66 : 896 - 900
  • [6] Immunotherapy highlights of the ASCO annual meeting 2018 for head and neck cancers
    Laban, S.
    Doescher, J.
    Busch, C. -J.
    Wollenberg, B.
    Dietz, A.
    Wuerdemann, N.
    Schuler, P. J.
    Hoffmann, T. K.
    [J]. HNO, 2018, 66 (12) : 880 - 887
  • [7] Current Treatment Concepts in Head and Neck Cancer Highlights of the 2018 ASCO Meeting
    Hoffmann, T. K.
    [J]. HNO, 2018, 66 (12) : 878 - 879
  • [8] Highlights from the ASCO annual meeting
    Printz, Carrie
    [J]. CANCER, 2013, 119 (17) : 3104 - 3105
  • [9] Current Treatment Concepts in Head and Neck Cancer Highlights of the 2016 ASCO Annual Meeting
    Knecht, R.
    [J]. HNO, 2016, 64 (10) : 699 - 699
  • [10] The ASCO 2018 annual meeting: update on the adjuvant treatment of early breast cancer
    Dormann C.
    J. Aichberger K.
    [J]. memo - Magazine of European Medical Oncology, 2018, 11 (4) : 272 - 275
12345